Atheln’s integrated product development and commercialization
(Click icons to view)
What we do
Atheln provides tailored strategic and operational solutions encompassing critical aspects of biopharma, biotech, and medtech product development and commercialization. Our expertise spans all stages of development and extends across a diverse range of therapeutic areas and technologies.
Our competencies include product development strategies and plans, nonclinical, CMC, regulatory, clinical, quality management, project management and leadership, product and commercial strategies and plans, business development, market access, pricing and reimbursement.
How we work with you
- Project based
- Integrating into your team for short-or long-term
- Ad hoc support including due diligence
- Fractional C-suite
- Interim management
Customized solutions
- Specialized experts or teams for each project
- Strategic and operational
- Single and/or multi-competency
- End-to-end integrated teams from early stage to commercial
Atheln’s experience spans diverse products/technologies and therapeutic areas
Types of products
- Biologics: recombinant, fusion and transgenic proteins, mAbs, ADCs, biosimilars, cell & gene therapies, vaccines
- Small Molecules
- Combination Products
Routes of administration
- Oral
- Injectables (IV, SC, IM, IVT, IC)
- Ophthalmic implants
- Topical (dermal, ocular)
- Transdermal
Therapeutic areas
- Addiction
- Aesthetics
- Autoimmune Diseases
- CNS
- Dermatology
- Endocrinology
- Gastroenterology
- Hematology
- Immunology
- Nephrology
- Oncology
- Ophthalmology
- Pain
- Rare Diseases
- Urology
